Robin Carhart-Harris

Dr. Robin Carhart-Harris is the Head of the Centre for Psychedelic Research, in the Department of Brain Sciences at Imperial College London, where he has designed a number of functional brain imaging studies with psilocybin (magic mushrooms), LSD, MDMA (ecstasy) and DMT (ayahuasca), plus clinical trials of psilocybin for treatment-resistant depression. His scientific contributions to psychedelic-assisted therapy could play a significant role in the future of psychedelics for mental health care.

CV

Robin Carhart-Harris got his PhD at the University of Bristol (2009) and has worked at Imperial College London since then. When the Centre for Psychedelic Research was founded, he became its director.

He was recently listed in the TIME100 NEXT list (2021) as one of the innovators.

He is a member of the (scientific) advisory board of Synthesis, MIND Foundation, Mydecine, Compass Pathways, Beckley Psytech, Entheon, Tryp Therapeutics, Qualia Research Institute, Journey Colab, Osmind, and Fireside Project.

Soon he will become the founding director of the Neuroscape Psychedelics Division at the University of California, San Francisco (UCSF).

Notable Research Papers

Find more on Google Scholar or PubMed

In our database you will also find him as an author on many more papers.

Media

He has given many talks:

More media:

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account